Furaloid en es it fr

Categoria

Furaloid Nombres de marca, Furaloid Analogos

Furaloid Marca los nombres de mezcla

  • No information avaliable
  • Furaloid Formula quimica

    C8H6N4O5

    Furaloid RX enlace

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Furaloid FDA hoja

    Furaloid MSDS (hoja de seguridad de materiales)

    Furaloid MSDS

    Furaloid Sintesis de referencia

    No hay información disponible

    Furaloid Peso molecular

    238.157 g/mol

    Furaloid Punto de fusion

    263 oC

    Furaloid H2O Solubilidad

    79.5 mg / L

    Furaloid Estado

    Solid

    Furaloid LogP

    -0.04

    Furaloid Formas de dosificacion

    Tableta

    Furaloid Indicacion

    Para el tratamiento de la infección del tracto urinario

    Furaloid Farmacologia

    Nitrofurantoína, un agente antibacteriano nitrofuranos, está disponible en forma microcristalina y macrocristalinas para tratar las infecciones del tracto urinario causada por muchas bacterias gram-negativas y algunas bacterias gram-positivas.

    Furaloid Absorcion

    No hay información disponible

    Furaloid Toxicidad

    No hay información disponible

    Furaloid Informacion de Pacientes

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Furaloid Organismos afectados

    Gram negativos y algunas bacterias gram positivas